88 results
Page 3 of 5
424B5
tzndh
2 Sep 22
Prospectus supplement for primary offering
4:46pm
8-K
10vjyjb6g
19 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
EX-99.1
9vrbaeah7nw2z xy
11 Aug 22
Aprea Therapeutics Reports Second Quarter 2022 Financial Results and Provides Update on Business Operations
4:26pm
PRE 14A
qfobjg7ft
27 May 22
Preliminary proxy
5:00pm
8-K
EX-99.1
zb3ky 1aumrafo3ii8lg
16 May 22
Entry into a Material Definitive Agreement
9:28pm
8-K
EX-99.1
u3c882ohhqc46jcmh4nr
16 May 22
Aprea Therapeutics Announces Acquisition of Atrin Pharmaceuticals Inc. and Reports First Quarter 2022 Financial Results
9:33am
8-K
EX-99.1
zy8rq
15 Mar 22
Aprea Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Update on Business Operations
4:23pm
8-K
EX-99.1
zwudm
8 Nov 21
Aprea Therapeutics Reports Third Quarter 2021 Financial Results and Provides Update on Business Operations
4:28pm
8-K
EX-99.1
ud23hbvxmqf5q
12 Aug 21
Aprea Therapeutics Reports Second Quarter 2021 Financial Results and Provides Update on Business Operations
4:25pm
8-K
EX-99.1
mtj96dr4ttigyzfzz7ss
6 May 21
Aprea Therapeutics Reports First Quarter 2021 Financial Results and Provides Update on Business Operations
4:22pm